We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Bowel Research Collaborative Data Tracking System Implementation Study

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00728975
First Posted: August 6, 2008
Last Update Posted: May 27, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Wyeth is now a wholly owned subsidiary of Pfizer
Information provided by:
British Columbia Cancer Agency
  Purpose
The project's primary purpose is to establish a network of Hospice Palliative Care settings using a common and consistent method of assessing and documenting bowel functioning in order to be able to carry out future collaborative studies of constipation treatments. The secondary goal is to gather normative data on current bowel care function and outcomes of current treatments which can be used to determine sample size calculations for future controlled trials of bowel management protocols. In order to complete this goal the project requires a thorough assessment of current nursing practice in regard to bowel care.

Condition
Constipation

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: The Bowel Research Collaborative Data Tracking System Implementation Study

Resource links provided by NLM:


Further study details as provided by British Columbia Cancer Agency:

Primary Outcome Measures:
  • Increased knowledge about normal bowel functioning in palliative care patients [ Time Frame: Immediate ]

Secondary Outcome Measures:
  • A system of bowel care patient data tracking in multiple collaborating sites will be established [ Time Frame: Immediate ]

Estimated Enrollment: 390
Study Start Date: June 2008
Study Completion Date: February 2010
Primary Completion Date: February 2010 (Final data collection date for primary outcome measure)
Groups/Cohorts
1
Pain and Symptom Management/Palliative Care Clinic outpatients, BC Cancer Agency, Vancouver Centre,
2
Pain and Symptom Management/Palliative Care Clinic outpatients, BC Cancer Agency, Centre for Southern Interior
3
Pain and Symptom Management/Palliative Care Clinic outpatients, BC Cancer Agency, Fraser Valley Centre
4
Pain and Symptom Management/Palliative Care Clinic outpatients, BC Cancer Agency, Vancouver Island Centre
5
Vancouver Coastal Cottage Hospice inpatients
6
Vancouver Coastal Richmond Palliative Care Program patients
7
Vancouver Coastal Lions Gate Palliative Care Unit inpatients
8
Providence Health St Paul's Hospital Palliative Care Unit inpatients
9
Providence Health Marion Hospice inpatients
10
Vancouver Island Health Authority Victoria Hospice inpatients
11
Fraser Health Burnaby Hospital Tertiary Palliative Care Unit inpatients
12
Fraser Health Mission Hospice inpatients
13
Fraser Health Langley Hospice inpatients

  Show Detailed Description

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Patients receiving palliative care
Criteria

Inclusion Criteria:

  • Patients receiving palliative care

Exclusion Criteria:

  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00728975


Locations
Canada, British Columbia
BC Cancer Agency
Vancouver, British Columbia, Canada, V5Z 4E6
Sponsors and Collaborators
British Columbia Cancer Agency
Wyeth is now a wholly owned subsidiary of Pfizer
Investigators
Principal Investigator: Philippa Dr Hawley, B.Med British Columbia Cancer Agency
  More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Philippa Hawley, Palliative Medicine Specialist, BC Cancer Agency
ClinicalTrials.gov Identifier: NCT00728975     History of Changes
Other Study ID Numbers: H08-01321
First Submitted: August 1, 2008
First Posted: August 6, 2008
Last Update Posted: May 27, 2010
Last Verified: February 2010

Keywords provided by British Columbia Cancer Agency:
constipation
cancer
palliative care
terminal
bowel

Additional relevant MeSH terms:
Constipation
Signs and Symptoms, Digestive
Signs and Symptoms